Berns Paul L
- SEC CIK
- 0001202769
In the past year, 2 open-market purchase filings worth $32.5M and 1 sale filing worth $34.5K.
Current role at each company
- NMRA Neumora Therapeutics, Inc.See Remarksas of Aug 21, 2026
- KARD Kardigan, Inc.Director, 10% Owneras of Jun 24, 2026
- LYEL Lyell Immunopharma, Inc.10% Owneras of Mar 9, 2026
- MTSR Metsera, Inc.Directoras of Nov 13, 2025
- UBX Unity Biotechnology, Inc.Directoras of Jun 21, 2024
Show 2 more companies
- EQRX EQRx, Inc.Directoras of Nov 9, 2023
- JAZZ Jazz Pharmaceuticals plcDirectoras of Aug 9, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $32.5M
- 2 filings
- Sold
- $34.5K
- 1 filing
- Net
- +$32.5M
- Bought minus sold
- Companies
- 3
- With open-market trades
Trades
Every Form 4 that lists Berns Paul L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
KARD Kardigan, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2026 (view filing) | Jun 22 | 2 days | Berns Paul LDirector, 10% Owner | PPurchase | +1.25M | $16.00 | +$20.0M | +9.1%15.0M after |
LYEL Lyell Immunopharma, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2026 (view filing)4:34 PM ET | Mar 6 | 3 days | Berns Paul L and 8 others10% Owner | PPurchase | +488.1K | $25.61 | +$12.5M | +52.0%1.43M after |
NMRA Neumora Therapeutics, Inc.
See Remarks2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2026 (view filing) | Feb 17 | 2 days | Berns Paul LSee Remarks | SSale | −9.82K | $3.51 | −$34.5K | −0.1%7.40M after | |
| Feb 20, 2025 (view filing) | Feb 18 | 2 days | Berns Paul LSee Remarks | SSale | −13.9K | $1.69 | −$23.4K | −0.2%7.41M after | 10b5-1 |
MTSR Metsera, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2025 (view filing) | Feb 3 | Same day | Berns Paul LDirector | PPurchase | +790.0K | $18.00 | +$14.2M | +10.5%8.31M after |
JAZZ Jazz Pharmaceuticals plc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2021 (view filing) | Aug 5 | 4 days | Berns Paul LDirector | SSale | −1.45K | $154.00 | −$223.3K | −14.9%8.29K after |